Litcius/Paper detail

Combining BRAF/MEK Inhibitors with Immunotherapy in the Treatment of Metastatic Melanoma

Dimitrios C. Ziogas, Frosso Konstantinou, Spyros Bouros, Maria Theochari, Helen Gogas

2021American Journal of Clinical Dermatology37 citationsDOI

Topics & Concepts

MedicineMelanomaImmunotherapyImmune checkpointImmune systemMetastatic melanomaIpilimumabTumor microenvironmentOncologyClinical trialCancer researchImmunologyInternal medicineMelanoma and MAPK PathwaysCancer Immunotherapy and BiomarkersCAR-T cell therapy research
Combining BRAF/MEK Inhibitors with Immunotherapy in the Treatment of Metastatic Melanoma | Litcius